Dataset summary
TF Name: | RUNX2 | Species: | Mus musculus |
Cell-type/Tissue: | matrix-depositing osteoblasts | Condition/Source: | |
JASPAR ID: | MA0511.2 | Collections: | Permissive Robust |
References: | GEO GSE54013 GSM1305864 GTRD EXP032845 |
Statistical details
Model | Peak caller | Model ID | Enrichment Zone | TFBSs | Score threshold | Centrality p-value (log10) |
---|---|---|---|---|---|---|
DAMO | MACS | MA0511.2 | 71 | 69597 | 85.2 | -18.787435713405 |
20 datasets found for the same TF (RUNX2) in other cell-types/tissues
TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
---|---|---|---|---|---|---|
RUNX2 | MC3T3-E1 (preosteoblasts) | ethanol vehicle | Permissive Robust | Mus musculus | GSE41920 ... | MA0511.2 |
RUNX2 | MC3T3-E1 (preosteoblasts) | ethanol vehicle | Permissive Robust | Mus musculus | GSE41920 ... | MA0511.2 |
RUNX2 | MC3T3-E1 (preosteoblasts) | 100nM 1,25(OH)2D3 | Permissive Robust | Mus musculus | GSE51513 ... | MA0511.2 |
RUNX2 | MC3T3-E1 (preosteoblasts) | 100nM 1,25(OH)2D3 | Permissive Robust | Mus musculus | GSE51513 ... | MA0511.2 |
RUNX2 | bone marrow-derived mesenchymal stem cells | osteogenic media day 7 | Permissive Robust | Mus musculus | GSE79813 ... | MA0511.2 |
RUNX2 | bone marrow-derived mesenchymal stem cells | osteogenic media day 15 | Permissive Robust | Mus musculus | GSE79813 ... | MA0511.2 |
RUNX2 | bone marrow-derived mesenchymal stem cells | adipose media day 7 | Permissive Robust | Mus musculus | GSE79813 ... | MA0511.2 |
RUNX2 | MCF7 (Invasive ductal breast carcinoma) | Full Medium + Doxycycline | Permissive Robust | Homo sapiens | GSE86538 ... | MA0511.2 |
RUNX2 | MLL-AF9 Leukemic Cells | Genotype: wildtype Strain: C57BL/6 Treatment: Ethanol | Permissive Robust | Mus musculus | GSE120063 ... | MA0511.2 |
RUNX2 | MLL-AF9 Leukemic Cells | Genotype: C1B knockout Strain: C57BL/6 Treatment: treated with 10-7M B-estradiol daily for two days (48 hours) | Permissive Robust | Mus musculus | GSE120063 ... | MA0511.2 |
RUNX2 | mineralizing osteoblasts | Permissive Robust | Mus musculus | GSE54013 ... | MA0511.2 | |
RUNX2 | bone marrow-derived mesenchymal stem cells | Permissive Robust | Mus musculus | GSE79813 ... | MA0511.2 | |
RUNX2 | bone marrow-derived mesenchymal stromal cells | Permissive Robust | Mus musculus | GSE76074 ... | MA0511.2 | |
RUNX2 | bone marrow-derived mesenchymal stromal cells | Permissive Robust | Mus musculus | GSE76074 ... | MA0511.2 | |
RUNX2 | bone marrow-derived mesenchymal stromal cells | Permissive Robust | Mus musculus | GSE76074 ... | MA0511.2 | |
RUNX2 | bone marrow-derived mesenchymal stromal cells | Permissive Robust | Mus musculus | GSE76074 ... | MA0511.2 | |
RUNX2 | SaOS2 (osteosarcoma) | Permissive Robust | Homo sapiens | GSE76937 ... | MA0511.2 | |
RUNX2 | MC3T3-E1 subclone 4 (preosteoblasts) | Permissive Robust | Mus musculus | GSE54013 ... | MA0511.2 | |
RUNX2 | Permissive | Homo sapiens | ERP003787 | MA0511.2 | ||
RUNX2 | LNCaP C4-2B (prostate carcinoma) | Permissive Robust | Homo sapiens | GSE33889 | MA0511.2 |